Connie Chang

Connie brings a diverse 25-year career in healthcare and business to ONL, having worked in both large and small pharma, early-stage biomedical technology commercialization and management consulting. She was most recently Vice President of Corporate Affairs at Millendo Therapeutics, a clinical stage biopharmaceutical company focused on orphan endocrine diseases, where, as a member of the executive leadership team, she was responsible for building critical infrastructure as the company became publicly traded, including investor and public relations, corporate communications, facilities and operations, information technology and corporate branding.

Prior to joining Millendo, Connie was the inaugural managing director of Fast Forward Medical Innovation (FFMI), the commercialization and entrepreneurship arm of the University of Michigan Medical School, with a mission to accelerate biomedical innovation by clinicians and researchers across campus. As a co-architect and leader of FFMI, Connie grew the team from a 4-person business development group, initially focused on growing collaborations with life science industry partners, into a multi-pronged and externally funded 12-person organization supporting early-stage technologies through translational research funding, industry networks, mentoring and other entrepreneurial support.

Connie moved back to her home state of Michigan after a 15-year career in Boston and New York, including 12 years in the pharmaceutical industry where she worked in leadership roles in commercial marketing and sales. At Sepracor (now Sunovion) Connie was Senior Director and brand team leader for the sedative hypnotic and respiratory franchises, leading the commercial business units for the prescription medicines Lunesta and Xopenex, and developing integrated marketing plans and sales force strategies for 2000+ sales professionals, including the launch of product line extensions. Prior to Sepracor, Connie was with Pfizer in New York working on commercial teams across multiple categories such as allergy/respiratory, cardiovascular and depression/anxiety, as well as serving as Director of Regional Marketing for the New England region. She also was a management consultant with Mercer in New York (now Oliver Wyman).

Connie received her Bachelor of Arts degree in psychobiology from Harvard University, graduating magna cum laude and Phi Beta Kappa, and an MBA from Harvard Business School.